...
首页> 外文期刊>Biochemistry >Selectin ligands and tumor-associated carbohydrate structures: specificities of alpha 2,3-sialyltransferases in the assembly of 3'-sialyl-6-sialyl/sulfo Lewis a and x, 3'-sialyl-6'-sulfo Lewis x, and 3'-sialyl-6-sialyl/sulfo blood group T-hapten.
【24h】

Selectin ligands and tumor-associated carbohydrate structures: specificities of alpha 2,3-sialyltransferases in the assembly of 3'-sialyl-6-sialyl/sulfo Lewis a and x, 3'-sialyl-6'-sulfo Lewis x, and 3'-sialyl-6-sialyl/sulfo blood group T-hapten.

机译:选择素配体和肿瘤相关的碳水化合物结构:3'-唾液酸-6-唾液酸/磺化Lewis a和x,3'-唾液酸-6'-磺化路易斯x和3的装配中α2,3-唾液酸转移酶的特异性-唾液酸-6-唾液酸/磺基血型T-半抗原。

获取原文
获取原文并翻译 | 示例
           

摘要

The sequence in the assembly of the functional unit of selectin ligands containing sulfate, sialic acid, and fucose and also tumor-associated O-glycan structures was studied by examining the specificities of alpha 2,3-sialyltransferases (ST). The first enzyme, porcine liver ST, was 57, 37, and 79% active (Km: 0.105, 0.420, and 0.200 mM), respectively, toward 6-sulfo, 6-sialyl, or 6-O-methyl derivatives of the Gal beta 1,3GalNAc alpha- unit; C-3 or C-6 substitution on Gal abolished sialylation. An acrylamide copolymer (MW approximately 40,000) containing approximately 40 T-haptens and asialo Cowper's gland mucin (MW approximately 200,000) containing approximately 48 T-haptens was 5-fold more active as an acceptor as compared to Gal beta 1, 3GalNAc alpha-O-Al on a molecular weight basis. The second enzyme, a cloned alpha-2,3-ST specific for lactose-based structure, was 70, 102, and 108% active (Km: 0.500, 0.210, and 0.330 mM), respectively, toward 6-sialyl, 6-sulfo, or 6-O-methyl derivatives of the Gal beta 1,3GlcNAc beta- unit; C-3 and C-6 substitution on Gal abolished sialylation. Gal beta 1,4GlcNAc beta- and its 6-sulfo derivative were approximately 20% active; the Lewis a structure, Gal beta 1,3- (Fuc alpha 1,4)GlcNAc beta-, was not an acceptor. The acrylamide copolymers containing approximately 40 units of Gal beta 1,3GlcNAc beta-, Gal beta 1,3(6-sulfo)GlcNAc beta-, or fetuin triantennary asialo or bovine IgG diantennary glycopeptides were respectively 5.9-, 5.4-, 0.7-, and 0.1-fold as active. A transfer of 7-9 mol of NeuAc per mole of the above copolymers was catalyzed by this ST, the sialyl linkage being susceptible to alpha 2,3-specific sialidase. A partially purified Colo 205 Lewis type (alpha 1, 3/4) fucosyltransferase catalyzed the formation of 3'-sialyl-6-sulfo Lewis a from [9-3H]NeuAc alpha 2, 3Gal beta 1, 3(6-sulfo)GlcNAc beta-O-Allyl and copolymer containing [9-3H]NeuAc alpha 2, 3Gal beta 1, 3(6-sulfo)GlcNAc beta- units, using GDP[14C]Fuc as fucosyl donor. The third enzyme, HL-60 ST, was 103%active with Gal beta 3(6-sulfo)GalNAc alpha- but was only 8% active with 6-sialo compound; it showed 11.6-fold greater activity with the copolymer of T-hapten. Further, we observed the alpha 2,3 sialylation of Gal beta 1,4GlcNAc beta- but not Gal beta 1,3GlcNAc beta- by HL60-ST, consistent with the occurrence of 3'-sialyl LacNAc and 3'-sialyl Lewis x units in leukosialin of HL60.(ABSTRACT TRUNCATED AT 400 WORDS)
机译:通过检查α2,3-唾液酸转移酶(ST)的特异性,研究了包含硫酸盐,唾液酸和岩藻糖的选择素配体的功能单元组装中的序列,以及与肿瘤相关的O-聚糖结构。第一种酶,猪肝ST,对Gal的6-磺基,6-唾液酸基或6-O-甲基衍生物分别具有57%,37%和79%的活性(Km:0.105、0.420和0.200 mM)。 beta 1,3GalNAc alpha-单位; Gal上的C-3或C-6取代取消了唾液酸化作用。与Gal beta 1、3GalNAc alpha-O相比,包含约40个T-半抗原的丙烯酰胺共聚物(MW约40,000)和包含约48 T-半抗原的无唾液酸考珀氏腺粘蛋白(MW约200,000)的受体活性高5倍。 -基于分子量的Al。第二种酶是对基于乳糖的结构具有特异性的克隆的alpha-2,3-ST,对6-唾液酸基,6--唾液酸基的活性分别为70、102和108%(Km:0.500、0.210和0.330 mM)。 Gal beta 1,3GlcNAc beta-单元的磺基或6-O-甲基衍生物; Gal上的C-3和C-6取代消除了唾液酸化作用。 Gal beta 1,4GlcNAc beta-及其6-磺基衍生物的活性约为20%; Lewis a结构Gal Gal 1,3-(Fuc alpha 1,4)GlcNAc beta-不是受体。含有约40个单位的Galβ1,3GlcNAcβ-,Gal beta 1,3(6-磺基)GlcNAcβ-或胎蛋白三天线脱唾液酸或牛IgG双天线糖肽的丙烯酰胺共聚物分别为5.9-,5.4-,0.7-,和活性的0.1倍。该ST催化每摩尔上述共聚物转移7-9摩尔NeuAc,唾液酸键易受α2,3-特异性唾液酸酶的影响。部分纯化的Colo 205 Lewis型(alpha 1,3/4)岩藻糖基转移酶催化了从[9-3H] NeuAc alpha 2、3Gal beta 1、3(6-sulfo)形成3'-唾液酸-6-磺基Lewis a的过程。 GlcNAcβ-O-烯丙基和含有[9-3H] NeuAcα2、3Galβ1、3(6-磺基)GlcNAcβ-单元的共聚物,使用GDP [14C] Fuc作为岩藻糖基供体。第三种酶HL-60 ST对Gal beta 3(6-磺基)GalNAcα-具有103%的活性,而对6-唾液酸化合物的活性仅为8%;它显示出与T-半抗原的共聚物相比,活性提高了11.6倍。此外,我们观察到HL60-ST对Gal beta 1,4GlcNAc beta-而不是Gal beta 1,3GlcNAc beta-进行α2,3唾液酸化,这与3'-唾液酸LacNAc和3'-唾液酸Lewis x单元的出现一致HL60的leukosialin中的片段(摘要以400字截断)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号